Indian Government Decides to Assess the Impact of FDI in Pharma Companies
A report of the Parliamentary Standing Committee on Commerce had suggested that a study group be set up to investigate the effect of FDI in brownfield pharma or operational firms.
A report of the Parliamentary Standing Committee on Commerce had suggested that a study group be set up to investigate the effect of FDI in brownfield pharma or operational firms.
"The company (Kilitch Drugs India) shall be a partner to the tune of 97 percent and the Ethiopian partner shall hold remaining 3 percent in the said joint venture," it added.
Shares of Kilitch Drugs India were trading a steep 19.97 percent up at Rs 38.15 per scrip during afternoon session on the BSE.
Indian Pharma Companies Need Strong Digital Dose: D Yellow Elephant Study
Indian pharma sector -- whether Indian companies or global players, lag behind their international counterparts by at least 5-7 years on digital platforms.
Indian pharma sector -- whether Indian companies or global players, lag behind their international counterparts by at least 5-7 years on digital platforms.
Indian Pharma Industry Has Enormous Opportunities To Discover New Drugs: Sun Pharma
Pharmaceutical companies are setting up labs abroad due to lack of expertise in India, so the core areas such as clinical development and research capabilities should be strengthened.
Pharmaceutical companies are setting up labs abroad due to lack of expertise in India, so the core areas such as clinical development and research capabilities should be strengthened.
Indian Pharma Receives USFDA Approval For Anti-Psychotic Drugs
Aripiprazole tablets are atypical antipsychotic indicated in the treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder.
Aripiprazole tablets are atypical antipsychotic indicated in the treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder.
